
Clearside Biomedical Inc
NASDAQ:CLSD

Intrinsic Value
The intrinsic value of one
CLSD
stock under the Base Case scenario is
0.8157
USD.
Compared to the current market price of 0.8998 USD,
Clearside Biomedical Inc
is
Overvalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Clearside Biomedical Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Clearside Biomedical Inc
Balance Sheet Decomposition
Clearside Biomedical Inc
Current Assets | 21.3m |
Cash & Short-Term Investments | 20m |
Receivables | 507k |
Other Current Assets | 747k |
Non-Current Assets | 3.9m |
PP&E | 3.8m |
Other Non-Current Assets | 30k |
Free Cash Flow Analysis
Clearside Biomedical Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Clearside Biomedical Inc
Revenue
|
1.7m
USD
|
Cost of Revenue
|
-149k
USD
|
Gross Profit
|
1.5m
USD
|
Operating Expenses
|
-30.4m
USD
|
Operating Income
|
-28.9m
USD
|
Other Expenses
|
-5.5m
USD
|
Net Income
|
-34.4m
USD
|
CLSD Profitability Score
Profitability Due Diligence
Clearside Biomedical Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Score
Clearside Biomedical Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
CLSD Solvency Score
Solvency Due Diligence
Clearside Biomedical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
Clearside Biomedical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CLSD Price Targets Summary
Clearside Biomedical Inc
Dividends
Current shareholder yield for CLSD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CLSD
stock under the Base Case scenario is
0.8157
USD.
Compared to the current market price of 0.8998 USD,
Clearside Biomedical Inc
is
Overvalued by 9%.